» Articles » PMID: 37175853

Role of CGAS-Sting Signaling in Alzheimer's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 13
PMID 37175853
Authors
Affiliations
Soon will be listed here.
Abstract

There is mounting evidence that the development of Alzheimer's disease (AD) interacts extensively with immunological processes in the brain and extends beyond the neuronal compartment. Accumulation of misfolded proteins can activate an innate immune response that releases inflammatory mediators and increases the severity and course of the disease. It is widely known that type-I interferon-driven neuroinflammation in the central nervous system (CNS) accelerates the development of numerous acute and chronic CNS diseases. It is becoming better understood how the cyclic GMP-AMP synthase (cGAS) and its adaptor protein Stimulator of Interferon Genes (STING) triggers type-I IFN-mediated neuroinflammation. We discuss the principal elements of the cGAS-STING signaling pathway and the mechanisms underlying the association between cGAS-STING activity and various AD pathologies. The current understanding of beneficial and harmful cGAS-STING activity in AD and the current treatment pathways being explored will be discussed in this review. The cGAS-STING regulation offers a novel therapeutic opportunity to modulate inflammation in the CNS because it is an upstream regulator of type-I IFNs.

Citing Articles

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer's Disease.

Medd M, Yon J, Dong H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996845 PMC: 11854763. DOI: 10.3390/cimb47020124.


Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.

Serradas M, Ding Y, Martorell P, Kulinska I, Castro-Gomez S Cells. 2024; 13(17.

PMID: 39272998 PMC: 11394242. DOI: 10.3390/cells13171426.


mosGraphGPT: a foundation model for multi-omic signaling graphs using generative AI.

Zhang H, Huang D, Chen E, Cao D, Xu T, Dizdar B bioRxiv. 2024; .

PMID: 39149314 PMC: 11326168. DOI: 10.1101/2024.08.01.606222.


Type I interferon signaling, cognition and neurodegeneration following COVID-19: update on a mechanistic pathogenetic model with implications for Alzheimer's disease.

Vavougios G, Tseriotis V, Liampas A, Mavridis T, de Erausquin G, Hadjigeorgiou G Front Hum Neurosci. 2024; 18:1352118.

PMID: 38562226 PMC: 10982434. DOI: 10.3389/fnhum.2024.1352118.


cGAS-STING, an important signaling pathway in diseases and their therapy.

Li Q, Wu P, Du Q, Hanif U, Hu H, Li K MedComm (2020). 2024; 5(4):e511.

PMID: 38525112 PMC: 10960729. DOI: 10.1002/mco2.511.


References
1.
Stetson D, Medzhitov R . Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006; 24(1):93-103. DOI: 10.1016/j.immuni.2005.12.003. View

2.
Kujirai T, Zierhut C, Takizawa Y, Kim R, Negishi L, Uruma N . Structural basis for the inhibition of cGAS by nucleosomes. Science. 2020; 370(6515):455-458. PMC: 7584773. DOI: 10.1126/science.abd0237. View

3.
Wu Z, Oeck S, Phillip West A, Mangalhara K, Sainz A, Newman L . Mitochondrial DNA Stress Signalling Protects the Nuclear Genome. Nat Metab. 2020; 1(12):1209-1218. PMC: 7213273. DOI: 10.1038/s42255-019-0150-8. View

4.
Kumar V . The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA. Front Immunol. 2021; 11:624597. PMC: 7905024. DOI: 10.3389/fimmu.2020.624597. View

5.
Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S . NAD supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. Proc Natl Acad Sci U S A. 2021; 118(37). PMC: 8449423. DOI: 10.1073/pnas.2011226118. View